George Yancopoulos

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) said Tuesday that a lower dose of its treatment for COVID-19 reduced hospitalization and death rates. This is "good news that could be really big news," Regeneron President George Yancopoulos said on CNBC's "Squawk Box." What...

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) has received ample support from multiple catalysts this week. On Tuesday, the company announced FDA approval for its prefilled Eylea syringe. The good news continued Wednesday with a positive clinical readout. What Happened Regeneron said positive top-...

Atopic dermatitis treatment candidate Dupixent jointly developed by Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA (ADR)(NYSE: SNY) has scaled the regulatory hurdle, a day ahead of the scheduled FDA examination day. The companies said the FDA has okayed Dupixent Injection, the first...